These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21553000)

  • 21. Management of psoriatic arthritis: Early diagnosis, monitoring of disease severity and cutting edge therapies.
    Raychaudhuri SP; Wilken R; Sukhov AC; Raychaudhuri SK; Maverakis E
    J Autoimmun; 2017 Jan; 76():21-37. PubMed ID: 27836567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and incidence rates of cardiovascular, autoimmune, and other diseases in patients with psoriatic or psoriatic arthritis: a retrospective study using Clinical Practice Research Datalink.
    Edson-Heredia E; Zhu B; Lefevre C; Wang M; Barrett A; Bushe CJ; Cox A; Wu JJ; Maeda-Chubachi T
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):955-63. PubMed ID: 25352213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and Clinical Characteristics of Psoriatic Arthritis in Japan.
    Ohara Y; Kishimoto M; Takizawa N; Yoshida K; Okada M; Eto H; Deshpande GA; Ritchlin CT; Tanaka A; Higashiyama M; Matsui K; Tsuji S
    J Rheumatol; 2015 Aug; 42(8):1439-42. PubMed ID: 26077408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular comorbidities in psoriasis and psoriatic arthritis: pathogenesis, consequences for patient management, and future research agenda: a report from the GRAPPA 2009 annual meeting.
    Boehncke WH; Gladman DD; Chandran V
    J Rheumatol; 2011 Mar; 38(3):567-71. PubMed ID: 21362790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between psoriatic arthritis and moderate-severe psoriasis: analysis of a series of 166 psoriatic arthritis patients selected from a hospital population.
    Busquets-Pérez N; Rodriguez-Moreno J; Gómez-Vaquero C; Nolla-Solé JM
    Clin Rheumatol; 2012 Jan; 31(1):139-43. PubMed ID: 21701797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set.
    Leung YY; Orbai AM; Ogdie A; Coates LC; de Wit M; Callis Duffin K; Eder L; Gladman DD; Goel N; Mease PJ; Strand V; FitzGerald O; Tillett W
    J Rheumatol Suppl; 2019 Jun; 95():33-37. PubMed ID: 31154402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Comorbidity on Physical Function in Patients With Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics: Results From a Cross-Sectional Study.
    Fernández-Carballido C; Martín-Martínez MA; García-Gómez C; Castañeda S; González-Juanatey C; Sánchez-Alonso F; García de Vicuña R; Erausquin-Arruabarrena C; López-Longo J; Sánchez MD; Corrales A; Quesada-Masachs E; Chamizo E; Barbadillo C; Bachiller-Corral J; Cobo-Ibañez T; Turrión A; Giner E; Llorca J; González-Gay MA;
    Arthritis Care Res (Hoboken); 2020 Jun; 72(6):822-828. PubMed ID: 31033231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The burden of carotid artery plaques is higher in patients with psoriatic arthritis compared with those with psoriasis alone.
    Eder L; Jayakar J; Shanmugarajah S; Thavaneswaran A; Pereira D; Chandran V; Rosen CF; Gladman DD
    Ann Rheum Dis; 2013 May; 72(5):715-20. PubMed ID: 22736087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of skin, musculoskeletal and psychosocial aspects on quality of life in psoriatic arthritis patients: A cross-sectional study of outpatient clinic patients in the biologic treatment era.
    Haugeberg G; Michelsen B; Kavanaugh A
    RMD Open; 2020 May; 6(1):. PubMed ID: 32409518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subclinical carotid atherosclerosis in patients with psoriatic arthritis.
    Tam LS; Shang Q; Li EK; Tomlinson B; Chu TT; Li M; Leung YY; Kwok LW; Wong KC; Li TK; Yu T; Zhu TY; Kun EW; Yip GW; Yu CM
    Arthritis Rheum; 2008 Sep; 59(9):1322-31. PubMed ID: 18759318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prevalence of psoriatic arthritis in people with psoriasis.
    Ibrahim G; Waxman R; Helliwell PS
    Arthritis Rheum; 2009 Oct; 61(10):1373-8. PubMed ID: 19790120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional impairment measurement in psoriatic arthritis: Importance and challenges.
    Mease P; Strand V; Gladman D
    Semin Arthritis Rheum; 2018 Dec; 48(3):436-448. PubMed ID: 30029795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between metabolic syndrome and carotid intima-media thickness: cross-sectional comparison between psoriasis and psoriatic arthritis.
    Lin YC; Dalal D; Churton S; Brennan DM; Korman NJ; Kim ES; Husni ME
    Arthritis Care Res (Hoboken); 2014 Jan; 66(1):97-103. PubMed ID: 23983044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomarkers for comorbidities in psoriasis: a report from the GRAPPA 2011 annual meeting.
    Gladman DD
    J Rheumatol; 2012 Nov; 39(11):2193-5. PubMed ID: 23118285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and clinical features of psoriatic arthritis in psoriasis patients in Spain. Limitations of PASE as a screening tool.
    López Estebaránz JL; Zarco-Montejo P; Samaniego ML; García-Calvo C;
    Eur J Dermatol; 2015; 25(1):57-63. PubMed ID: 25333645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-Effectiveness of Secukinumab Versus Other Biologics in the Treatment of Psoriatic Arthritis: An Argentinean Perspective.
    Aiello E; Bianculli PM; Bhattacharyya D; Gunda P; Citera G
    Value Health Reg Issues; 2019 Dec; 20():86-94. PubMed ID: 31103950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis.
    Husted JA; Thavaneswaran A; Chandran V; Eder L; Rosen CF; Cook RJ; Gladman DD
    Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1729-35. PubMed ID: 21905258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.
    Woolacott N; Bravo Vergel Y; Hawkins N; Kainth A; Khadjesari Z; Misso K; Light K; Asseburg C; Palmer S; Claxton K; Bruce I; Sculpher M; Riemsma R
    Health Technol Assess; 2006 Sep; 10(31):iii-iv, xiii-xvi, 1-239. PubMed ID: 16948890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measuring psoriatic arthritis symptoms: A core domain in psoriasis clinical trials.
    Perez-Chada LM; Gottlieb AB; Cohen J; Mease P; Duffin KC; Garg A; Latella J; Armstrong AW; Ogdie A; Merola JF
    J Am Acad Dermatol; 2020 Jan; 82(1):54-61. PubMed ID: 31163240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group.
    Ogdie A; de Wit M; Callis Duffin K; Campbell W; Chau J; Coates LC; Eder L; Elmamoun M; FitzGerald O; Gladman DD; Goel N; James J; Kalyoncu U; Latella J; Lindsay C; Mease PJ; O'Sullivan D; Steinkoenig I; Strand V; Tillett W; Orbai AM
    J Rheumatol; 2017 May; 44(5):697-700. PubMed ID: 28461531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.